NCT03777865View on ClinicalTrials.gov

Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions
Vaccines
Interventions
BIOLOGICAL

13vPnC

All subjects receive a single dose (0.5mL) of 13vPnC

Trial Locations (4)

560017

Manipal Hospital / Department of Pediatrics, Bengaluru

600034

Kanchi Kamakoti CHILDS Trust Hospital, Chennai, Tamil Nadu

411 011

KEM Hospital Research Centre, Pune

141 008

Christian Medical College, Ludhiana

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03777865 - Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India | Biotech Hunter | Biotech Hunter